Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
3,995.00
3,967.00
5,527.00
5,705.00
5,544.00
3,801.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4,736.00
-1,048.00
-1,456.00
2,194.00
1,033.00
-3,583.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
282.00
3,966.00
4,959.00
8,388.00
7,130.00
1,024.00
Cash Flow from Investing Activities
-4,240.00
-6,686.00
-3,844.00
-8,646.00
-1,403.00
-1,349.00
Cash Flow from Financing Activities
-109.00
-1,105.00
-2,207.00
15.00
-1,812.00
1,377.00
Net Cash Inflow / Outflow
-4,063.00
-3,817.00
-1,084.00
-242.00
3,914.00
1,046.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
7.00
8.00
0.00
0.00
-5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
3995.37420944849
-289.766411476205
4,284.00
1478.83%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4736.21868362027
-67.0212968244109
-4,669.00
-6966.74%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
282.2303152368
-168.39405765089
450.00
267.60%
Cash Flow from Investing Activities
-4240.4563286626
268.995935325347
-4,508.00
-1676.40%
Cash Flow from Financing Activities
-109.252383119502
-231.792962617493
122.00
52.87%
Net Cash Inflow / Outflow
-4063.30073047708
-127.866854641917
-3,936.00
-3077.76%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.17766606821655
3.32423030111856
1.00
25.67%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -92.88% vs -20.02% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
282.23
3,966.66
-92.88%






